Urinary Caffeine And Caffeine Metabolites, Biological Aging, And Cardiovascular-Kidney-Metabolic Syndrome: Deciphering Association, Mediation, And Mechanism Via Epidemiology And Bioinformatics
Many of us start our day with a cup of coffee or tea, enjoying the stimulating effects of caffeine. But beyond the morning jolt, what are the long-term health implications of this widely consumed substance? Recent research sheds light on this by investigating the relationship between the body’s caffeine breakdown products and a complex health condition known as cardiovascular-kidney-metabolic (CKM) syndrome. CKM syndrome is a serious disorder that involves problems with the heart, kidneys, and metabolism, such as high blood sugar and unhealthy cholesterol levels. This new study looked at the levels of various caffeine metabolites—the substances caffeine turns into after being processed by the body—in urine. The findings suggest a fascinating connection: individuals with higher levels of these caffeine metabolites in their urine appear to have a reduced risk of advanced CKM syndrome. Specifically, certain individual caffeine breakdown products, like 1,7-dimethylxanthine and 1,3-dimethylxanthine, were linked to this protective effect. The research also delved into the potential biological mechanisms, exploring how these caffeine metabolites might influence pathways within our cells to offer this protection. This work highlights the potential role of caffeine, through its metabolic byproducts, in influencing our long-term cardiovascular, kidney, and metabolic health.
Source: link to paper